The University of Chicago Header Logo

Connection

Husain Sattar to Humans

Back to Details
This is a "connection" page, showing publications Husain Sattar has written about Humans.
Husain Sattar
Connection Strength
0.102
Humans
  1. Lobular neoplasia of the breast: an update. Arch Pathol Lab Med. 2009 Jul; 133(7):1116-20.
    View in: PubMed
    Score: 0.012
  2. Multiple paragangliomata of the lungs and temporal bone. Ear Nose Throat J. 2008 Nov; 87(11):E4-6.
    View in: PubMed
    Score: 0.011
  3. Primary follicular dendritic cell sarcoma of the lung. Histopathology. 2006 Oct; 49(4):431-3.
    View in: PubMed
    Score: 0.010
  4. The presence of a CD21+ follicular dendritic cell network distinguishes invasive Quilty lesions from cardiac acute cellular rejection. Am J Surg Pathol. 2006 Aug; 30(8):1008-13.
    View in: PubMed
    Score: 0.009
  5. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 11 01; 157(11):1034-1041.
    View in: PubMed
    Score: 0.007
  6. Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants. J Clin Invest. 2022 09 01; 132(17).
    View in: PubMed
    Score: 0.007
  7. Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials. Ann Oncol. 2022 08; 33(8):814-823.
    View in: PubMed
    Score: 0.007
  8. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663.
    View in: PubMed
    Score: 0.007
  9. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362.
    View in: PubMed
    Score: 0.006
  10. Angular restriction fluorescence optical projection tomography to localize micrometastases in lymph nodes. J Biomed Opt. 2019 11; 24(11):1-4.
    View in: PubMed
    Score: 0.006
  11. WNT10B/ß-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Mol Med. 2013 Feb; 5(2):264-79.
    View in: PubMed
    Score: 0.004
  12. Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802.
    View in: PubMed
    Score: 0.004
  13. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
    View in: PubMed
    Score: 0.003
  14. Computerized three-class classification of MRI-based prognostic markers for breast cancer. Phys Med Biol. 2011 Sep 21; 56(18):5995-6008.
    View in: PubMed
    Score: 0.003
  15. The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Cancer Cell. 2010 Aug 09; 18(2):160-70.
    View in: PubMed
    Score: 0.003
  16. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model. Transplantation. 1994 Jun 27; 57(12):1786-94.
    View in: PubMed
    Score: 0.001
  17. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation. 1994 Jun 15; 57(11):1537-43.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.